Analyst Ratings for PTC Therapeutics (PTCT)
PTCT Rating Summary
PTCT Price Target Summary
- Highest: $200.00 (Rosenblatt)
- Lowest: $54.00 (Leerink Partners)
- Average: $96.94
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$96.94 (+54.3%)
* Over Last 12-Mos
Rating Score: 5.8 / 10
Percentile Rank: 62%
Avg. $ Target:
$96.94 (+54.3%)
* Over Last 12-Mos
Rating Score: 5.8 / 10
Percentile Rank: 62%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/28/2026 | Barclays » Updated 2/23/2026 |
Eliana Merle | New Coverage | Overweight (N/A) |
120.00 (119.00) |
76.23 (62.82) |
-17.59% | Details |
| 12/1/2025 | RBC Capital » Updated 2/20/2026 |
Brian Abrahams | Downgrade | Sector Perform (Outperform) |
82.00 (87.00) |
85.99 (62.82) |
-26.94% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
